Rachel Narozniak, MA

The investigators evaluated whether the participation of fellows at different stages of training affects the selection of polypectomy strategy.

The Leona M. and Harry B. Helmsley Charitable Trust awarded grants to 3 studies, the results from which will inform evidence-based recommendations for dietary intervention in Crohn disease.

New York University (NYU), Columbia University, and Takeda Pharmaceuticals have announced a 5-year research alliance aimed at driving advances in gastroenterology and hepatology.

The Pancreatic Cancer Action Network has launched an adaptive clinical trial platform that will enroll patients with pancreatic cancer across 15 sites nationwide.

Five Prime Therapeutics, Inc. announced topline data from the phase 2 FIGHT study comparing bemarituzumab and chemotherapy with chemotherapy alone.

Investigators of the retrospective cohort study evaluated adherence to guideline-supported eradication testing for Helicobacter pylori infection.

Investigators studied the association between gastroesophageal reflux disease and non–small lung cancer in a retrospective case-control study.

Paul J. Limburg, MD, highlights the significance of the United States Preventive Services Task Force’s draft guidance for colorectal cancer screening.

Investigators evaluated the impact of insurance status on gastric cancer survival outcomes in patients treated at a safety-net hospital.

Trio-SmartTM, a novel new breath test developed to measure hydrogen, methane, and hydrogen sulfide, is now available and can be ordered on the test’s website.